A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State
NCT03882255
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ponesimod dose range (2 - 20 mg)
DRUG:
Placebo Propranolol
DRUG:
Propranolol 80 mg
Sponsor
Janssen Pharmaceutica N.V., Belgium